SCHEMBL27697478

SCHEMBL27697478

C=CC1(Nc2ncnc3sc(CC)cc23)C=CC=CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.47
▸ TSHR P16473 3/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2C9 P11712 2/20 0.46
▸ SELE P16581 5/20 0.44
▸ VCAM1 P19320 5/20 0.44
▸ ICAM1 P05362 4/20 0.44
▸ HPGD P15428 3/20 0.43
▸ LMNA P02545 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ HTT P42858 3/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ MEN1 O00255 5/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ HRH4 Q9H3N8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27736388 0.70 KDM4E (0.35) KDM4EHPGDLMNAHTTALDH1A1
SCHEMBL27306975 0.70 SMN1; SMN2 (0.41) KDM4EHPGDLMNASMN1; SMN2HTT
SCHEMBL7259398 0.68 KDM4E (0.65) KDM4ETSHRCYP1A2CYP2C9SELE
SCHEMBL13583876 0.67 KDM4E (0.56) KDM4ETSHRCYP1A2CYP2C9SELE
SCHEMBL27850019 0.66 EGFR (0.48) —
SCHEMBL19444541 0.64 KDM4E (0.95) KDM4ETSHRCYP1A2CYP2C9SELE
SCHEMBL13644104 0.63 SELE (0.65) KDM4ETSHRCYP1A2CYP2C9SELE
SCHEMBL13583873 0.63 KDM4E (0.79) KDM4ETSHRCYP1A2CYP2C9SELE
SCHEMBL13641274 0.63 KDM4E (0.79) KDM4ETSHRCYP1A2CYP2C9SELE
SCHEMBL10343611 0.63 KDM4E (0.79) KDM4ETSHRCYP1A2CYP2C9SELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101061122-A Novel thieno-pyridine and thieno-pyrimidine derivatives and their use as positive allosteric modulators of mglur2-receptors JANSSEN PHARMACEUTICA NV (BE) 2007-10-24 — — CN disclosed
Send feedback